Retention and attendance with supervised buprenorphine treatment: a case-note review.

Saved in:

Bibliographic Details
Title:	Retention and attendance with supervised buprenorphine treatment: a case-note review.
Authors:	Bell, James, Burrell, Tracy
Source:	Drug & Alcohol Review. Mar2006, Vol. 25 Issue 2, p161-165. 5p. 3 Charts.
Subjects:	Buprenorphine, Treatment of heroin abuse, Detoxification (Substance abuse treatment), Rehabilitation of people with drug addiction
Geographic Terms:	Australia
Abstract:	Since 2001, the Langton Centre has used supervised administration of buprenorphine in treating heroin dependence, without distinguishing between detoxification and maintenance; most people commencing treatment may remain on buprenorphine indefinitely. The aim of this study was to describe retention in treatment, reasons for leaving, re-entry and pattern of attendance, and compare retention in practice with results from research trials, using a file review of sequential presentations for buprenorphine treatment. Retention in treatment was 37% at 6 months, the same as in Australian research trials of buprenorphine maintenance (37%); most people dropped-out without consultation or dose tapering. Repeated episodes of treatment constituted 45% of all episodes; missed scheduled doses were common. Participation in buprenorphine treatment often involves repeated, short episodes and erratic attendance. Measures to improve retention in treatment could improve treatment efficacy. [Bell J, Burrell T. Retention and attendance with supervised buprenorphine treatment: a case-note review . Drug Alcohol Rev 2006;25:161 – 165] [ABSTRACT FROM AUTHOR]
	Copyright of Drug & Alcohol Review is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database:	Psychology and Behavioral Sciences Collection

Description
Abstract:	Since 2001, the Langton Centre has used supervised administration of buprenorphine in treating heroin dependence, without distinguishing between detoxification and maintenance; most people commencing treatment may remain on buprenorphine indefinitely. The aim of this study was to describe retention in treatment, reasons for leaving, re-entry and pattern of attendance, and compare retention in practice with results from research trials, using a file review of sequential presentations for buprenorphine treatment. Retention in treatment was 37% at 6 months, the same as in Australian research trials of buprenorphine maintenance (37%); most people dropped-out without consultation or dose tapering. Repeated episodes of treatment constituted 45% of all episodes; missed scheduled doses were common. Participation in buprenorphine treatment often involves repeated, short episodes and erratic attendance. Measures to improve retention in treatment could improve treatment efficacy. [Bell J, Burrell T. Retention and attendance with supervised buprenorphine treatment: a case-note review . Drug Alcohol Rev 2006;25:161 – 165] [ABSTRACT FROM AUTHOR]
ISSN:	09595236
DOI:	10.1080/09595230500537647